ALD518

BIOLOGICAL4 trials

Sponsors

CSL Behring

Conditions

Acute GvHDArthritis, RheumatoidCachexiaFatigueNSCLCOral Mucositis

Phase 1

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

TerminatedNCT01530256

CSL BehringAcute GvHD

Start: 2012-03-31End: 2013-03-31Updated: 2021-02-17

Phase 2

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

CompletedNCT00867516

CSL BehringArthritis, Rheumatoid

Start: 2008-10-31End: 2009-12-31Updated: 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CompletedNCT00866970

CSL BehringCachexia, Fatigue, NSCLC

Start: 2008-09-30End: 2009-12-31Updated: 2020-07-09

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

TerminatedNCT01403064

CSL BehringOral Mucositis

Start: 2011-07-31End: 2014-03-31Updated: 2021-05-11